Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review

GlobalData
47 Pages - GLDATA62866
$125.00

Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet forms. Its products are indicated to treat multiple sclerosis, influenza infection, multiple myeloma, leukemia, Crohn's disease, hypertension, Myelodysplastic syndrome and prostate cancer and others. Natco Pharma offers active pharmaceutical ingredients (APIs) for the domestic and international markets. It manages five API and finished dosage facilities and a research center in India. The company operates in India, the US, Canada, and Europe. Natco Pharma is headquartered in Hyderabad, Telangana, India.

Natco Pharma Ltd Key Recent Developments

Feb 14,2017: NATCO records INR 685.13 Crore total consolidated revenue and INR 194.76 Crore of profit, after tax, for the Third Quarter, FY 2017 14 February 2017
Jan 25,2017: NATCO updates on USFDA inspection at its Kothur Formulation Facility
Nov 11,2016: NATCO records INR 467.86 Crore operating revenue for the Second Quarter, FY 2017, ended September 2016
Aug 25,2016: NATCO receives Establishment Inspection Report for Chennai facility
Aug 16,2016: Natco Receives Establishment Inspection Report For Kothur Facility

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

'

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Natco Pharma Ltd - Key Facts 6
Natco Pharma Ltd - Key Employees 7
Natco Pharma Ltd - Key Employee Biographies 8
Natco Pharma Ltd - Major Products and Services 9
Natco Pharma Ltd - Pharmaceutical Pipeline Products Data 10
Natco Pharma Ltd, Pipeline Products by Therapy Area 10
Natco Pharma Ltd, Pipeline Products by Development Phase 11
Natco Pharma Ltd - History 12
Natco Pharma Ltd - Company Statement 14
Natco Pharma Ltd - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 16
Section 2 – Company Analysis 17
Natco Pharma Ltd - Business Description 17
Natco Pharma Ltd - Corporate Strategy 18
Natco Pharma Ltd - SWOT Analysis 19
SWOT Analysis - Overview 19
Natco Pharma Ltd - Strengths 19
Natco Pharma Ltd - Weaknesses 20
Natco Pharma Ltd - Opportunities 21
Natco Pharma Ltd - Threats 22
Natco Pharma Ltd - Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios - Interim Ratios 29
Financial Ratios - Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32
Natco Pharma Ltd, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
Feb 14, 2017: NATCO records INR 685.13 Crore total consolidated revenue and INR 194.76 Crore of profit, after tax, for the Third Quarter, FY 2017 14 February 2017 34
Jan 25, 2017: NATCO updates on USFDA inspection at its Kothur Formulation Facility 35
Nov 11, 2016: NATCO records INR 467.86 Crore operating revenue for the Second Quarter, FY 2017, ended September 2016 36
Aug 25, 2016: NATCO receives Establishment Inspection Report for Chennai facility 37
Aug 16, 2016: Natco Receives Establishment Inspection Report For Kothur Facility 38
Aug 09, 2016: Natco Pharma Announces First quarter Results for 2016 39
May 26, 2016: Natco Pharma Announces Q4 & FY16 Results 40
Mar 27, 2016: Natco updates on USFDA Inspection 41
Feb 11, 2016: NATCO records Rs.281.40 crores revenue for the Third Quarter, ended December 2015 42
Section 6 – Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Natco Pharma Ltd, Key Facts 6
Natco Pharma Ltd, Key Employees 7
Natco Pharma Ltd, Key Employee Biographies 8
Natco Pharma Ltd, Major Products and Services 9
Natco Pharma Ltd, Number of Pipeline Products by Therapy Area 10
Natco Pharma Ltd, Number of Pipeline Products by Development Stage 11
Natco Pharma Ltd, History 12
Natco Pharma Ltd, Other Locations 15
Natco Pharma Ltd, Subsidiaries 15
Natco Pharma Ltd, Joint Venture 16
Natco Pharma Ltd, Key Competitors 23
Natco Pharma Ltd, Ratios based on current share price 24
Natco Pharma Ltd, Annual Ratios 25
Natco Pharma Ltd, Annual Ratios (Cont...1) 26
Natco Pharma Ltd, Annual Ratios (Cont...2) 27
Natco Pharma Ltd, Interim Ratios 29
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32
Natco Pharma Ltd, Recent Deals Summary 33
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46

List of Figures
Natco Pharma Ltd, Pipeline Products by Therapy Area 10
Natco Pharma Ltd, Pipeline Products by Development Phase 11
Natco Pharma Ltd, Performance Chart (2012 - 2016) 28
Natco Pharma Ltd, Ratio Charts 30
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 32

$125.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838